dimethyl fumarate stada gastroresistentne kõvakapsel
stada arzneimittel ag - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 180tk; 240mg 60tk; 240mg 100tk; 240mg 14tk
fosclera gastroresistentne kõvakapsel
norameda uab - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk
dimethyl fumarate zentiva gastroresistentne kõvakapsel
zentiva k.s. - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 100tk; 120mg 14tk
dimethyl fumarate zentiva gastroresistentne kõvakapsel
zentiva k.s. - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 56tk
fosclera gastroresistentne kõvakapsel
norameda uab - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 56tk
dimethyl fumarate tevapharm gastroresistentne kõvakapsel
teva gmbh - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk
dimethyl fumarate tevapharm gastroresistentne kõvakapsel
teva gmbh - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 168tk
tecfidera
biogen netherlands b.v. - dimetüülfumaraat - hulgiskleroos - immunosupressandid - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - sclerosis multiplex, relapsing-remitting - immunosupressandid - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
dimethyl fumarate mylan
mylan ireland limited - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.